Literature DB >> 17213406

Natriuretic peptides and cardiovascular events: more than a stretch.

Marvin A Konstam.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17213406     DOI： 10.1001/jama.297.2.212

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Nona Sotoodehnia; Christopher DeFilippi; David S Siscovick; John S Gottdiener; Richard A Kronmal
Journal:  Heart Rhythm       Date:  2010-10-30       Impact factor: 6.343

2.  Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).

Authors:  Anuradha Lala; Steven E McNulty; Robert J Mentz; Shannon M Dunlay; Justin M Vader; Omar F AbouEzzeddine; Adam D DeVore; Prateeti Khazanie; Margaret M Redfield; Steven R Goldsmith; Bradley A Bart; Kevin J Anstrom; G Michael Felker; Adrian F Hernandez; Lynne W Stevenson
Journal:  Circ Heart Fail       Date:  2015-06-03       Impact factor: 8.790

3.  Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.

Authors:  Ramon Paniagua; Dante Amato; Salim Mujais; Edward Vonesh; Alfonso Ramos; Ricardo Correa-Rotter; Walter H Horl
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 8.237

4.  Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.

Authors:  Konstantinos P Letsas; Gerasimos S Filippatos; Loukas K Pappas; Constantinos C Mihas; Virginia Markou; Ioannis P Alexanian; Michalis Efremidis; Antonios Sideris; Alan S Maisel; Fotios Kardaras
Journal:  Clin Res Cardiol       Date:  2008-10-30       Impact factor: 5.460

5.  Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

Authors:  Christopher R deFilippi; Robert H Christenson; John S Gottdiener; Willem J Kop; Stephen L Seliger
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 27.203

6.  Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.

Authors:  Reneta Yovcheva Koycheva; Vasil Cholakov; Jivko Andreev; Margarit Penev; Rosen Iliev; Krasimira Nancheva; Vanya Tsoneva
Journal:  Open Access Maced J Med Sci       Date:  2015-12-30

7.  N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.

Authors:  Madeline R Sterling; Raegan W Durant; Joanna Bryan; Emily B Levitan; Todd M Brown; Yulia Khodneva; Stephen P Glasser; Joshua S Richman; George Howard; Mary Cushman; Monika M Safford
Journal:  BMC Cardiovasc Disord       Date:  2018-04-16       Impact factor: 2.298

Review 8.  A review on B-type natriuretic peptide monitoring: assays and biosensors.

Authors:  Rita Maalouf; Steven Bailey
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.